NIAMS offers R03 small grants to K01/K08/K23/K25 awardees in years 2-4 to boost research capabilities as they transition to independent investigator status; clinical trials are not allowed.
NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.
The NHLBI Emerging Investigator Award (EIA) provides long-term support for experienced PDs/PIs with a strong research record to make significant contributions to heart, lung, blood, and sleep research.
This grant provides salary and travel support for experienced, non-tenure track scientists in core labs or research facilities who make essential contributions to NCI-funded cancer research but are not independent investigators.
The NHLBI OIA supports experienced researchers with exceptional HLBS research records, offering long-term funding for innovative research programs, enhancing productivity, fostering creativity, and supporting mentorship.